Compare PepsiCo, Inc. (PEP) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PepsiCo, Inc. vs Tempus AI — how do they compare? PepsiCo, Inc. trades at $128.14 (market cap $168.88B), while Tempus AI trades at $70.04 (market cap $12.77B). The key difference: PepsiCo, Inc. is far larger — about 13.2× Tempus AI's market cap, and PepsiCo, Inc. pays a 4.78% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold PepsiCo, Inc. for 107 Days and Tempus AI for 22 Days on average.
| PEP | TEM | |
|---|---|---|
Market Cap | $168.88B | $12.77B |
Volume | 13,263,972 | 8,980,490 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $170.44 | $99.28 |
52-Week Low | $123.64 | $41.55 |
Typical Hold Time | 107 Days | 22 Days |
Enterprise Value | $211.38B | $13.40B |
Dividend Yield | 4.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $128.88, up 2.52% today, with strong earnings momentum as it has beaten EPS estimates for four consecutive quarters. The stock shows bearish technical signals from moving averages but bullish oscillators, trading near support at $123. Fundamentally, PEP maintains solid profitability with 10.78% net margin and 51.59% ROE, though revenue growth remains modest at 2.2% in 2025. Recent news highlights price adjustments on snack products to address consumer pushback on high prices.
PEP offers value with a 16.22 P/E below industry averages and a 12.7% upside to the $145.25 consensus target, supported by 30% analyst buy ratings. However, risks include competitive pressure, margin compression from pricing actions, and technical weakness. The company's consistent dividend and earnings beats provide stability, but investors should monitor North American sales recovery and inflation impacts.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
